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General anesthesia has long been considered a safe means of enabling pediatric surgery, unpleasant pro-cedures, or medical imaging. However, concerns have 
accumulated that fetuses, babies, and young children exposed 
to general anesthesia may experience long-lasting neurotoxic 
effects.1 Approximately 200,0002 of the 4 million3 children 
below 6 years of age in the United Kingdom undergo gen-
eral anesthesia annually (5%), making the risk of anesthetic-
induced neurotoxicity a critical public health issue.
Preclinical studies demonstrate that exposure to all 
commonly used IV and inhalational anesthetic agents is 
associated with altered brain development in immature ani-
mals including nonhuman primates.4,5 Single long exposures6 
and multiple exposures7 adversely affect neurodevelopment. 
The duration and timing of exposure influence the neurotoxic 
potential of general anesthetic agents. The brain is thought to 
be particularly vulnerable during the period of synaptogene-
sis.4 In humans, this “vulnerable time window” is reportedly 
between the third trimester and 2–3 years of age.6,8–11
Human observational studies of anesthetic-induced neu-
rotoxicity are heterogeneous in their methodologies and offer 
contrary conclusions. Studies of single brief general anesthe-
sia for minor procedures are generally reassuring, but worse 
long-term neurodevelopmental outcome has been reported 
following prolonged/repeated exposure.1 Pooled effect esti-
mates from observational studies indicate at least a modest 
risk of impaired neurodevelopment following general anes-
thesia for surgery in childhood.12,13 To date, only 1 ongoing 
randomized controlled trial of awake-spinal versus sevoflu-
rane general anesthesia for herniorrhaphy before 60 weeks 
postmenstrual age has reported secondary outcomes.14 The 
General Anesthesia compared to Spinal trial reassuringly finds 
equivalent cognitive scores between groups at 2 years of age. 
However, more comprehensive cognitive assessment in later 
childhood could still detect anesthetic-induced neurotoxicity.
Increasing numbers of original studies and an exponen-
tial increase in review articles on pediatric anesthetic neu-
rotoxicity over the past 10 years (Figure 1) have prompted 
regulatory and professional bodies to release precautionary 
statements concerning pediatric general anesthesia. The US 
Food and Drug Administration cautions against lengthy/
Neurodegeneration has been reported in young animals after exposure to all commonly used 
general anesthetic agents. The brain may be particularly vulnerable to anesthetic toxicity during 
peak synaptogenesis (in gestation and infancy). Human studies of long-term neurodevelopmen-
tal outcome following general anesthesia in early childhood report contradictory findings. This 
review assesses the strengths and deficiencies in human research methodologies to inform 
future studies. We identified 76 studies, published between 1990 and 2017, of long-term neu-
rodevelopmental outcome following early childhood or in utero general anesthesia exposure: 49 
retrospective, 9 ambidirectional, 17 prospective cohort studies, and 1 randomized controlled 
trial. Forty-nine studies were explicitly concerned with anesthetic-induced neurotoxicity. Full texts 
were appraised for methodological challenges and possible solutions. Major challenges identified 
included delineating effects of anesthesia from surgery, defining the timing and duration of expo-
sure, selection of a surgical cohort and intervention, addressing multiple confounding life course 
factors, detecting modest neurotoxic effects with small sample sizes (median, 131 children; 
interquartile range, 50–372), selection of sensitive neurodevelopmental outcomes at appropri-
ate ages for different developmental domains, insufficient length of follow-up (median age, 6 
years; interquartile range, 2–12 years), and sample attrition. We discuss potential solutions to 
these challenges. Further adequately powered, multicenter, prospective randomized controlled 
trials of anesthetic-induced neurotoxicity in children are required. However, we believe that the 
inherent methodological challenges of studying anesthetic-induced neurotoxicity necessitate the 
parallel use of well-designed observational cohort studies.  (Anesth Analg 2019;128:681–94)
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repeated general anesthesia or sedation in the third trimester 
and in children younger than 3 years old.17 Guidance from 
the United Kingdom and Ireland20 and a statement from 
European bodies19 advocate avoiding unnecessary general 
anesthesia but recommend no changes to clinical practice.
There has been much discussion of the limitations of the 
existing human evidence base for anesthetic-induced neu-
rotoxicity. Therefore, to inform the design of future clinical 
studies, we identified and reviewed the 76 clinical studies 
of long-term neurodevelopmental outcome following early 
childhood or in utero general anesthesia exposure that were 
published between 1990 and April 2018 (Supplemental 
Digital Content, Appendix 1, http://links.lww.com/AA/
C723) to identify particular challenges encountered in per-
forming these types of studies, as well as feasible pragmatic 
methodological solutions. We sought methods used to iso-
late the effects of general anesthesia from surgery/disease, 
characterize anesthetic exposure and surgical intervention, 
address confounding, detect marginal neurotoxic effects, 
and define what the implications of the research are for clin-
ical practice. These are summarized in Table 1.
DELINEATING THE NEUROTOXIC EFFECT OF 
ANESTHESIA
Perhaps the greatest challenge to studying anesthetic-
induced neurotoxicity is in separating direct toxic effects 
of general anesthesia on the brain from indirect effects of 
anesthesia (disturbance of normal physiology, eg, hypoxia, 
hyperoxia, hypotension, and hypothermia),30 surgery (stress 
response31 and systemic inflammation), and the periopera-
tive course (complications, pain,27 artificial or inadequate 
nutrition52). We illustrate this concept in Figure 2A.
All but 2 studies14,53 make comparisons between general 
anesthesia and surgery groups, with or without control 
and therefore cannot distinguish anesthesia-induced effects 
from surgery-induced effects. Although methodologically 
ideal, a 2 × 2 factorial design (anesthesia yes/no × surgery 
yes/no) to determine the effect of anesthesia on neurode-
velopment would be logistically and ethically challenging 
in children or animals and arguably not possible.
A pragmatic nonrandomized study might compare (a) 
general anesthesia without surgery, eg, undergoing imaging, 
endoscopic, or interventional procedures; (b) general anes-
thesia with surgery, and (c) no general anesthesia or surgery.21 
Careful choice of the category (a) children would be required. 
For example, children undergoing neuroimaging may have 
comorbidities that are independent risk factors for poor neuro-
developmental outcome.21 Category (c) controls could be non-
hospitalized siblings/classmates or hospitalized nonsurgical 
children. It is important that children who undergo additional 
surgeries in later childhood are not excluded from either the 
intervention or control groups to avoid selection biases.32
Spinal anesthesia in immature rats has been shown to 
not accelerate neuronal apoptosis or cause neurobehavioral 
abnormality.54 An ideal randomized study, therefore, could 
compare (a) general anesthesia for surgery, (b) awake-
regional anesthesia for surgery, and (c) no anesthesia or 
surgery controls. The General Anesthesia compared to 
Spinal trial14 adopted a similar strategy in children under-
going general anesthesia/surgery or intended to undergo 
awake-spinal anesthesia for inguinal herniorrhaphy. In 
reality, this approach restricts the sample to children under-
going infraumbilical procedures for which awake-neurax-
ial anesthesia is a feasible alternative to general anesthesia 
Figure 1.  Cumulative number of human observational studies and randomized controlled trials of neurodevelopment following general anes-
thesia exposure at age <6 years (thick black line) and those specifically designed to study anesthetic-induced neurotoxicity (dotted line). We 
place this in the context of the number of commentaries and review articles (dashed line) and milestone statements and publications con-
cerning anesthetic-induced neurotoxicity. Smart Tots 1: Smart Tots consensus statement on the use of anesthetics and sedatives in children 
201215; Smart Tots 2: consensus statement on the use of anesthetic and sedative drugs in infants and toddlers 201516; GAS trial: General 
Anesthesia compared to Spinal randomized controlled trial secondary outcomes published 201614; FDA: US Food and Drug Administration 
safety communication 201617; ANZCA and SPANZA: joint warning from the Australian and New Zealand College of Anaesthetists and the 
Society for Paediatric Anaesthesia in New Zealand and Australia 201618; European bodies: consensus statement of the European Society of 
Anaesthesiology, the European Society for Paediatric Anaesthesiology, the European Association of Cardiothoracic Anaesthesiology and the 
European Safe Tots Anaesthesia Research Initiative 201719; UK and Ireland bodies: joint professional guidance on the use of general anes-
thesia in young children 2017.20 ANZCA indicates Australian and New Zealand College of Anaesthetists; FDA, Food and Drug Administration; 
GAS, General Anesthesia compared to Spinal; SPANZA, Society for Paediatric Anaesthesia in New Zealand and Australia.
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and may therefore limit external generalizability to other 
patient groups. Careful control or adjustment for differ-
ential incidence of deranged physiology between general 
anesthesia and awake-regional anesthesia groups (eg, 
significant hypotension more common in the former55) is 
required to avoid biasing results. Furthermore, children 
with inadequate blocks or who do not tolerate awake-
regional anesthesia may require sedation or conversion to 
general anesthesia (18% in the General Anesthesia com-
pared to Spinal trial but may be up to 80%56), which may 
defeat the purpose of the study design. However, per pro-
tocol analyses of noninferiority or equivalence trials where 
there is a crossover of patients between exposure categories 
would still test whether general anesthesia was harmful to 
child neurodevelopment.
THE TOXIC EXPOSURE TO GENERAL ANESTHESIA
Although brain structure and function develop throughout 
childhood, a period of peak synaptogenesis in early child-
hood has strong implications for later cognition, language, 
and social behavior.6,39 Exposure during this “vulnerable 
time window” of brain development ought to be the focus 
of anesthetic research. Although its timing is well defined in 
animal species, with the overwhelming majority of studies 
performed on postnatal day 7 in rats,11,32 human anesthetic-
induced neurotoxicity studies have quoted a heterogeneous 
range of definitions, eg, “third trimester to 2 years,”8 “third 
trimester to 6 weeks,”9 “0–36 months,”33 “early gestation 
through to infancy,”10 or “birth to 2–3 years.”57 The concept 
of a single vulnerable time window may be an oversimpli-
fication since there are significant regional differences in 
the timing and pace of peak synaptogenesis,32,58 which are 
reflected in discordant results for different domains of neu-
rodevelopment.34,59–61 Furthermore, the age of the neuron as 
opposed to the age of the child can determine vulnerability 
to anesthetics.46,62 At present, it seems pragmatic to investi-
gate general anesthesia exposures up to 3 years of age.
Since most of the studies (n = 49; 64.5%) employ retro-
spective observational designs and many were not designed 
to investigate anesthetic-induced neurotoxicity per se (n=27, 
35.5%),35,63–72 data concerning anesthetic exposure are often 
limited. Some investigators make assumptions that, if incor-
rect, could undermine their studies, eg, babies are presumed 
to undergo general anesthesia for minor procedures that may 
have been conducted under regional anesthesia10; or circumci-
sion is presumed to be performed without general anesthesia 
in the perinatal period but under general anesthesia for older 
children in another study.46 Whether randomized or nonran-
domized prospective or retrospective designs, anesthetic-
induced neurotoxicity studies need to strive to accurately 
ascertain the exposure of each child to avoid underestimating 
the true effect of general anesthesia (false-negative results).
A dose-response relationship has been detected with 
increasing numbers of coadministered anesthetic agents57 
and been sought by comparing single versus multiple anes-
thetic exposures.40,41 However, because dose and duration of 
general anesthesia vary widely between procedures, these 
are poor surrogates for cumulative dose of anesthetic drug 
Table 1.  Challenges and Potential Solutions in Human Studies of Anesthetic-Induced Neurotoxicity
Challenges Solutions
Measuring direct 
neurotoxic effects of 
general anesthesia
• Nonrandomized observational design: compare (a) general anesthesia only, (b) general anesthesia + surgery, (c) no 
general anesthesia or surgery21
• Randomized controlled trial: compare (a) general anesthesia + surgery, (b) awake-regional anesthesia + surgery,14 (c) 
no general anesthesia or surgery
Defining the general 
anesthesia exposure
• Accurate ascertainment of general anesthesia exposure including duration, drugs, age-adjusted MAC-hours for 
inhalational agents,22–24 or cumulative mg/kg for IV agents25
• Use of electronic anesthetic record keeping systems makes this feasible
Selection of surgical 
cohort and procedure
• Study otherwise healthy elective surgical cohorts that have no independent risk factors for poor neurodevelopmental 
outcome26
• Select common, relatively minor surgery, eg, inguinal herniorrhaphy14,27,28 or surgery for solitary urogenital problems29
Addressing multiple 
confounding factors
• Careful selection and thorough measurement of potential confounders
• Randomized controlled trial: evenly distribute known and unknown confounders across groups through randomization14
• Nonrandomized observational design: (a) control for differences in known confounders using regression9,25,30–38 or 
matching techniques39–42; (b) address potential impacts of unmeasured confounding through statistical simulation43
• Undertake a Mendelian randomization study44,45
Detecting modest 
neurotoxic effects
• Maximize statistical power by (a) studying large samples in the order of 103 to 105 children46,47; (b) comparing 
exposed to unexposed children in 1:4 ratio38,47,48
• Study longer duration general anesthesia, ie, ≥1 h
• Study general anesthesia during the “vulnerable time window” of brain development,6,8–11 ie, <3 years of age
Measurement of 
neurodevelopmental 
outcome
• Assessment in multiple domains of development using a battery of sensitive, validated outcomes49,50: (a) 
age-normalized intelligence scores, (b) academic achievement in standardized national tests, (c) a battery of 
developmental assessments, (d) risk scores for neuropsychiatric disorders
• Prospective evaluation by trained, blinded assessors49,50
Length of follow up and 
sample attrition
• Follow-up until at least school age to allow deficits to manifest in domains of development, which become amenable 
thorough neuropsychological testing in school age children14,24,33
• Ascertain and report reasons for loss to follow up
• Address missing data depending on the mechanism of data loss51: missing at random—multiple imputation; missing 
not at random—sensitivity experiments
Abbreviations: IV, intravenous; MAC, minimum alveolar concentration.
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exposure.34 Furthermore, inaccurate reporting of compos-
ite procedures, eg, adenoidectomy/tonsillectomy/myr-
ingotomy, may lead to misclassification of children to the 
multiple-exposure group.73 Children requiring repeated 
procedures may have confounding reasons for poor neuro-
developmental outcome, which may not be captured in the 
study data set. Ideally, dose–response analyses ought to use a 
prospectively determined duration of anesthesia in minutes 
for specified drugs or dose in age-adjusted minimum alveo-
lar concentration-hours for inhalational agents22–24 or cumu-
lative milligram per kilogram for IV anesthesia.25 This level 
of detail may be more achievable with electronic anesthetic 
record-keeping systems.
CHOICE OF INTERVENTION
In observational studies, selection of participants in terms 
of their diagnosis/disease and surgical procedure ought 
to minimize “confounding by indication”—a scenario 
in which the disease or the surgery itself is an indepen-
dent risk factor for poor neurodevelopmental outcome. 
Studies of neurosurgical and cardiothoracic surgical 
cohorts,35,74 as well as children operated on with major 
congenital or chromosomal abnormalities52,75 are classi-
cally affected. However, studies of general anesthesia for 
neuroimaging,21 some otorhinolaryngology procedures 
(eg, adenotonsillectomy for obstructive sleep apnea asso-
ciated with learning difficulty40,76 or myringotomy and 
grommet insertion associated with speech/language 
delay77), pyloromyotomy associated with significant 
hyperbilirubinemia32 or nutritional inadequacy,72 gastros-
chisis,60 craniosynostosis,30 and cancer surgery47 may be 
similarly compromised.
When selecting study participants, a balance ought to be 
struck between the risk of confounding by indication and 
being as inclusive as possible to maximize external valid-
ity. A healthy, elective surgical cohort undergoing relatively 
minor surgery would be ideal.26 Inguinal herniorrha-
phy14,27,28 or surgery for solitary urogenital problems29 (eg, 
circumcision or hypospadias repair) is common and has no 
known independent association with poor neurodevelop-
mental outcome. Particular care should be exercised if it is 
necessary to pool multiple surgical procedures to increase 
statistical power.36
Anesthetic agents readily cross the placental barrier, 
which has previously permitted studies in children born 
to occupationally exposed mothers78 and children born 
by cesarean delivery under general anesthesia.53,79,80 These 
studies may not demonstrate anesthetic-induced neuro-
toxicity because of the poorly defined, chronic low-dose 
occupational exposure or the relatively brief exposure at 
cesarean delivery. Studying anesthetic-induced neurotoxic-
ity in the context of (a) general anesthesia cesarean delivery 
versus (b) neuraxial anesthetic cesarean delivery and (c) 
spontaneous vertex delivery is also fraught with difficulty. 
Results may be confounded by opioids used for labor anal-
gesia, which may cause neonatal respiratory depression; or 
the use of labor epidural analgesia, which may reduce stress 
response in the control group.53 The indication for cesarean 
delivery intervention, as well as an increased frequency 
of prematurity, complications of pregnancy, and perina-
tal insults in the intervention groups may also confound 
results. Studying intrauterine surgery to correct fetal abnor-
malities would offer a longer well-defined general anes-
thetic drug exposure, but no such work has been published.
Figure 2.  Key concepts in the epidemiology of anesthetic-induced 
neurotoxicity (see text for detailed explanation). Arrows represent 
the direction of causality between variables. A, Impaired neurode-
velopmental outcome may result from direct neurotoxic effects of 
general anesthesia (the effect of interest) and/or indirect effects, 
which lie on different causal pathways that operate through mediator 
variables. B, Confounding variables are associated with the anes-
thetic exposure and also influence neurodevelopmental outcome, 
but do not lie on a causal pathway between anesthesia and neu-
rodevelopment. If confounders are not balanced through random-
ized study design or accounted for in statistical analyses, then the 
estimated direct neurotoxic effect of general anesthesia is biased. 
C, Collider variables are a common effect of general anesthesia 
exposure and neurodevelopmental outcome. Statistical adjustment 
for a collider variable that has been mistaken for a confounder can 
introduce collider-stratification bias. D, Mendelian randomization is 
a novel study design for unbiased causal inference in observational 
studies, which exploits the random allocation of genetic material 
during human reproduction to set up a natural analogy to a random-
ized controlled trial. It utilizes genetic variants that are selected to 
be associated with general anesthetic exposure (but importantly, not 
directly with impaired neurodevelopment) as instrumental variables.
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Table 2.  Potential Confounders of the Association Between Anesthesia and Neurodevelopment, Which Have 
Been Measured in Human Anesthetic-Induced Neurotoxicity Studies
Child Demographics
 Age/year of birth9,23,34,40–42,71,78,81–85 Language14,59
 Sex9,10,21,23,26,30,32,34–36,39–42,46,47,53,60,64,66,73,74,78,80,81,83–87 Month/quarter of birth (accounts for school entry cohorts)39,47
 Race/ethnicity10,21,30,31,34,42,46,64,86 Year of birth cohort (accounts for changes in assessment tool)10,39
Socioeconomic Characteristics
 Socioeconomic status23,35,40,64,65,74,82,85,87 Received income support9
 Housing class26 Involved in child welfare system9
 Household/maternal income9,34,46,47,66,86 Insurance system: eligibility status, provider40,80
 Years/level of education8,10,26,27,29,32,36,41,47,53,60,64,66,73,74,78,83,86,88 Geographical location, eg, zone improvement plan code/postal 
code38,40,48,87
 Occupation38,78 Urbanity/rurality of residence9,39,80
Family Composition
 Parental living arrangements: cohabiting, living with 1 parent/
guardian26,34,47
Number of siblings47
 Parental marital status80,87,89 Birth order26,87
 Parental death89 Sibships40
Other Parent/Guardian Factors
 Maternal intelligence quotient24,73,90 Race/nationality80
 Age at birth of (first) child8,9,27,32,36,39,53,80,87 Language spoken at home22,64,67,68,83,91
 Maternal parity80 Maternal smoking: never, prepregnancy, or in pregnancy73
 Medical history40 Maternal alcohol consumption: never, prepregnancy, or in pregnancy73,92
 Parental stress88 Developmental delay, mental disability, psychiatric disorder, autism, or 
attention-deficit/hyperactivity disorder 26
Childhood Influences
 Mentoring by older siblings26 Problems at school29
 Sports participation93 Childhood trauma29
Pregnancy and Peripartum
 Intrauterine growth retardation38,52 Labor analgesia: epidural, spinal, opioid, nitrous oxide
 Prematurity/gestational age at 
birth9,14,21–24,26,27,29,30,34,35,39,41,46,47,52,53,57,60,64,66,73–75,80,83,88,90,94,95
Mode of delivery: normal vaginal, assisted vaginal, Cesarean53,84
 Birth weight (centile)/small or large for gestational 
age8–10,21,22,24,27,29,32,34–36,41,46,48,52,53,60,63–65,74,75,80,81,83,84,90,93,94
Urgency of assisted or operative delivery
 Induction of labor53 Multiple birth cohort10
 Prolonged labor Intrauterine fetal distress
 Maternal complications of pregnancy, labor, or delivery38,42,53,80 Intrauterine or birth asphyxia/resuscitation at delivery38,48,66,88,89,96
5- or 10-min Apgar scores10,47,53,66,80,94
Perinatal Fetal Morbidity
 Respiratory distress syndrome or other neonatal respiratory 
disorder38,48,80
Fetal and neonatal hemorrhage, hemolytic disease of the newborn, or 
other hematological conditions38
 Endocrine and metabolic disturbances38,48 Perinatal infection38,48
 Perinatal jaundice38,80 Disorders of digestive system38
Past or Perioperative Neurological Status
 Microcephaly35,88/head circumference35,64 Preoperative neurodevelopmental scores30
 Magnetic resonance imaging brain maturity score24 Hand dominance23
 Magnetic resonance imaging intracranial volume34 Abnormal neurological examination23,88
 Number of sedated magnetic resonance imaging scans95 Mental/psychiatric disorder or disability24,41,89,92
 Meningitis10 Neurosurgery91
 Seizures10,97 Head trauma and/or loss of consciousness23
 Traumatic or ischemic CNS injury,29,90,92,95,97 brain malformation,88 
intracerebral hemorrhage,10 severe cystic periventricular 
leukomalacia,10 cerebral edema,80 stroke,66 cerebral palsy,30 or 
other neurological disease/injury14,26,48,57
 
Secondary Care Interaction
 Number/duration of admissions22,24,35,46,61,63,64,66,68,88,93 Followed by cardiologist or cardiovascular service39
 Number of outpatient clinic attendances46  
Anesthetic and Surgical Factors
 Indication for general anesthesia: type of surgery, imaging, or 
examination21,48,57
Age at general anesthesia21,25,30,35,57,64–66,68,88
 Diagnosis, eg, anatomical defect in cardiac surgery, site of 
craniosynostosis suture,30 and type of cleft lip and palate8
Weight at general anesthesia25,35,64,80,85
 Surgical center10,40 Bispectal index at the end of surgery31
 Surgical approach: open, minimally invasive88 Hemodynamic and respiratory instability during anesthetic92
 Complications of surgery57  
(Continued )
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ADDRESSING CONFOUNDING
The association between general anesthesia and neurode-
velopmental outcome is heavily confounded by factors 
throughout the life course (Figure  2B; Table  2). Properly 
conducted randomized controlled trials should evenly 
distribute known/measured and unknown/unmeasured 
confounders across groups at randomization, thereby over-
coming confounder bias.
Observational studies of anesthetic-induced neurotoxic-
ity must control (via restriction, stratification, or regression 
adjustment) for differences in known/measured confound-
ers between groups to avoid extensive bias. However, data 
concerning pregnancy/peripartum factors (eg, prematurity, 
fetal acidosis, birth asphyxia) and perioperative factors (eg, 
temperature, hypoxia/hyperoxia, hemodynamics, adverse 
events) are often unknown, especially in retrospective stud-
ies. Some factors that ought to be adjusted for, eg, American 
Society of Anesthesiologists physical status, are not routinely 
recorded for nonexposed children, and smaller studies may 
make no attempt to adjust for confounders at all.72,91,100,102–104 
By definition, unknown/unmeasured confounders cannot 
be controlled for, but their potential impacts on the results 
of observational studies can be simulated statistically.43
Adjustment for multiple potential confounders in obser-
vational studies is performed with the intention of reducing 
confounder bias. However, care must be exercised to avoid 
Other Child Medical History
 Genotype: genetic syndrome/genetic polymorphisms/
chromosomal abnormality/predisposition to neurodevelopmental 
disorders22,24–26,31,35,40,52,63–68,90,91,96,98,99
Composite morbidity scores, eg, Johns Hopkins Resource Utilization 
Band,9 John Hopkins Adjusted Diagnosis Group,84,86 and ASA physical 
status >II100
 Phenotype: (major or multiple) congenital anomalies/birth defects/
dysmorphic syndrome14,24,27,29,30,36,38,40,46,48,52,57,60,66,80,88,90,93,95,97,98
History of fetal intervention (radiotherapy, brachytherapy, 
pharmacotherapy, chemotherapy)39
 Other comorbidities likely to influence neurodevelopment: cardiac 
disease,26,57 Hirschsprung disease,66,73 retinoblastoma,66,73 Sturge-
Weber syndrome,101 severe renal disorders,26 endocrine disease,48 
jaundice,21,46,80 chronic respiratory disease, eg, bronchopulmonary 
dysplasia,10,57 strabismus surgery,102 cardiac surgery,65 or other 
significant health conditions requiring surgery30
Physical disabilities39
Past and Perioperative Critical Care Admissions
 Number/duration of admissions21,31,57,64,66,68,71,88,90 Cardiopulmonary arrest24,66,90
 Composite scores, eg, Parmelee Postnatal Complication Scale61 Nutrition: oral, artificial supplement, entirely artificial63
 Invasive or noninvasive ventilation: use of, duration14,21,34,64,68,93,95 Total parenteral nutrition: use of, prolonged use93
 Oxygen requirement, eg, preoperative Fio266 Necrotizing enterocolitis10,95
 Lowest Pao225,88 Gut perforation52
 Prenatal/postnatal steroids or respiratory distress10,31,95 Infections: number,95 complicated by sepsis10,52,93
 Hypotension66,95 Lowest temperature71
 Blood loss and coagulopathy30 Other perioperative complications: thromboembolic,66 hemorrhagic,66 
hypoxia,66 acidosis,66 hypocalcaemia,66 seizure66
 Volume of blood components given30  
Duration/Cumulative Doses of Other Drugs
 Opioids24,64,90 Chloral hydrate25
 Benzodiazepines24,25,64,90 Antiepileptic drugs23,92
 Ketamine25 Substance abuse92
Cardiac Surgery
 Prenatal diagnosis25,35,66 Diameter ascending aorta35
 Palliative or corrective surgery68,88 Indexed shunt diameter35
 Congenital lesion: cyanotic or acyanotic,88 1- or 2-ventricle 
circulation,24,25,35,63,66 anatomical defect, eg, tetralogy of Fallot, 
transposition of the great arteries, or ventricular septal defect 65
Patent ductus arteriosus (distinguish surgically closed)10,95
 Composite scores, eg, Society of Thoracic Surgeons mortality 
category,63 Aristotle score,66 Risk Adjustment for Congenital Heart 
Surgery25
Prostaglandin dependent66
 Somatic63 and cerebral regional24,63,90 Sao2: preoperative, 
intraoperative, and 72 h postoperatively
Extracorporeal membranous oxygenation: use, duration63,71
 Inotropes: duration, mean score24,25,35,64,66 CPB: use, duration24,31,35,63,64,88,90
 Duration of open sternum64 Deep hypothermic circulatory arrest: use, duration24,63–66,88
 Postoperative catheterization or reoperation66 Aortic cross-clamp: use, duration25,71
 Erythropoetin or aprotinin administration24,90 Selective cerebral perfusion time35
 Anticoagulant or antiplatelet drug at discharge66 Afterload reduction time35
Hematocrit: intraoperatively/postoperatively30 lowest on CPB,22 at the 
end of bypass, after hemodilution64
Other Biochemical Measurements
 Hypothalamic-pituitary-adenal axis, eg, baseline adrenocorticotropic  
hormone 31
Worst lactate or base excess intraoperatively and postoperatively64,66
 Adrenaline level Inflammation, eg, interleukin-6 at the end of surgery31
Abbreviations: ASA, American Society of Anesthesiologists; CNS, central nervous system; CPB, cardiopulmonary bypass; Fio2, fractional concentration of inspired 
oxygen.
Table 2. Continued
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“overadjustment”105—whereby this very process decreases 
precision or paradoxically increases net bias though several 
mechanisms. First, attempting to control for increasing num-
bers of variables reduces the precision of the neurotoxic effect 
estimates generated by statistical models. Wide (imprecise) 
CIs around the effect estimates may mask any evidence of 
anesthetic-induced neurotoxicity, leading to false-negative 
conclusions. The second mechanism concerns “intermediate 
variables,” which are distinguished from confounders by lying 
on the causal pathway between exposure and outcome. For 
example, we might speculate that anesthetic-induced neuro-
toxicity is mediated via hypotension (Figure 2A). In the case 
of multiple causal pathways between exposure and outcome, 
then mistakenly controlling for hypotension (or some descend-
ing proxy thereof such as volume of crystalloid or amount of 
vasoactive drug administered) would produce a null-biased 
result, ie, falsely reducing the apparent strength of any neuro-
toxic effect estimate. Worse still, if the only causal path between 
general anesthesia exposure and impaired neurodevelopment 
were mediated through hypotension, then mistakenly con-
trolling for this intermediate variable (or its proxies) ought to 
entirely nullify any neurotoxic effect estimate, again producing 
falsely reassuring conclusions. The third mechanism involves 
“collider variables,” which are defined as a common effect 
of the exposure and outcome (Figure  2C). Mistaken control 
for this common effect induces a spurious (noncausal) asso-
ciation between general anesthesia and neurodevelopmental 
outcome through which confounding can flow, paradoxically 
inducing bias (termed “collider-stratification bias”) into the 
neurotoxic effect estimate where none previously existed. An 
illustrative example comes from studies of prenatal pollutant 
exposure and long-term child neurodevelopment in which the 
pollutants also cause fetal loss.106 Since outcome can only be 
determined in live-born children, if investigators condition on 
live birth status (in this case by restriction to live-born children 
as is typical in pediatric cohort studies), bias arising from com-
mon causes of fetal death and long-term neurodevelopmen-
tal outcome (ie, confounders of the association between fetal 
death and neurodevelopment) is induced.
Collectively, the pitfalls of multivariable analysis neces-
sitate thoughtful selection of potential confounders, which 
may be assisted by drawing a “directed acyclic graph”107—
a visual representation of the assumed associations among 
exposure, outcome, and other measured/unmeasured vari-
ables using unidirectional arrows to represent the direc-
tion of causality (and temporality). These graphs distill 
the causal model underlying the epidemiological problem, 
informing the choice of confounding, intermediate and col-
lider variables, which would be required to build a statistical 
model to test for an unbiased relationship between general 
anesthesia and neurodevelopmental outcome. The afore-
mentioned pitfalls of multiple confounder adjustment also 
necessitate cautious “stepwise” modeling whereby poten-
tial confounders are sequentially added to the developing 
statistical model and its output scrutinized at each step for 
paradoxical effects. A sudden reversal of the effect estimate 
following the stepwise incorporation of the latest potential 
confounder, for example, may prompt a reevaluation of the 
causal assumptions regarding that variable and whether it 
may operate as a collider as opposed to a confounder in the 
causal model. It would be dangerous to simply attempt to 
simultaneously adjust for all measured child characteristics 
in a nonrandomized anesthetic-induced neurotoxicity study.
Conventional techniques for confounder adjustment 
include various regression models (eg, linear, logistic, Poisson 
or Cox proportional hazards modeling)9,25,30–38 and matching 
techniques. Group/frequency matching ensures that the pro-
portions of subjects with given characteristics are the same 
in each group.41,42 Individual/pair matching ensures that 
pairs of children, 1 from each group, share similar character-
istics.39,40 Results from matched pairs are less confounded but 
require larger sample sizes to achieve the same precision.
More innovative approaches may help uncover asso-
ciations. Propensity score analysis is a pragmatic choice of 
method to reduce the complexity and computational burden 
of statistical models, which attempt to control for a multitude 
of potential confounding variables in a nonrandomized study. 
It reduces the dimensionality of the data set from a large col-
lection of variables to a single propensity score, which is gen-
erated by a regression model from those variables that are 
thought to influence membership to the general anesthesia 
group in the study. The propensity score assigned to each 
child would take a value between 0 and 1 and represent the 
estimated probability of general anesthesia group member-
ship, conditional on the values of those variables thought 
to influence general anesthesia versus nongeneral anesthe-
sia group membership. The propensity score can then be 
adjusted for as an independent variable in a regression model 
(as opposed to entering the collection of known/measured 
confounders). Alternatively, one can match individual chil-
dren between general anesthesia and nongeneral anesthesia 
groups who have similar likelihoods of general anesthesia 
group membership (ie, similar propensity scores), such that 
known/measured confounders are balanced across the 2 gro
ups.10,23,27,38,46,74 These “propensity-adjusted” or “propensity-
matched” estimates of neurotoxic effect on neurodevelopment 
ought to be unbiased by known/measured confounders.
Mendelian randomization is an advance in observa-
tional epidemiology, which overcomes confounding by both 
known/measured and unknown/unmeasured factors. It 
can provide unbiased evidence for causal relations between 
a modifiable exposure and patient outcome.44,45 Instead of 
the traditional exposure variable (ie, general anesthesia/
surgery), it considers “instrumental variables” (Figure 2D). 
These are either one or a combination of multiple genetic 
variants (ie, alleles or single nucleotide polymorphisms) 
that are randomly allocated to children at meiosis in human 
reproduction and are selected on the basis that they robustly 
predict general anesthesia exposure without directly influ-
encing neurodevelopmental outcome (except via the gen-
eral anesthesia exposure itself). Candidate genetic variants 
are typically identified from large genome-wide association 
studies but could conceivably be associated with certain dis-
ease states (increasing the propensity for general anesthesia 
to facilitate procedures, medical imaging, or surgery) or with 
suxamethonium apnea or malignant hyperpyrexia (reduc-
ing the propensity for general anesthesia where there is an 
established child or family history). Random natural assort-
ment of genetic material ensures that instrumental variable 
status is independent of factors that confound the asso-
ciation between the traditional exposure variable (general 
anesthesia/surgery) and the neurodevelopmental outcome. 
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Once child outcomes are compared based on the instrumen-
tal variable (rather than general anesthesia exposure), then 
intergroup differences in general anesthesia exposure and 
neurodevelopment ought to reflect true, unconfounded 
causal relationships between general anesthesia/surgery and 
neurodevelopmental outcome (Figure 3). We believe that the 
Mendelian randomization approach to detecting anesthetic-
induced neurotoxicity may be especially feasible using a 
“2-sample” Mendelian randomization in which data linking 
the chosen genetic variants to general anesthesia exposure 
need not come from the same sample as data that link general 
anesthesia exposure to neurodevelopment. No observational 
studies of anesthetic-induced neurotoxicity published to date 
have used Mendelian randomization. However, it offers the 
potential to elucidate an unconfounded link between anes-
thesia and neurodevelopment using what is an efficient natu-
ral analogy to a randomized controlled trial.
As an illustrative example, the effect of prenatal alcohol 
exposure on child academic achievement has been studied 
recently using the Mendelian randomization approach.108,109 
Here, researchers have exploited genetic variation in the 
alcohol dehydrogenase gene as an instrument for in utero 
alcohol exposure. Mothers with the rare allele metabolize 
alcohol faster, resulting in more rapid production of etha-
nol metabolites that cause unpleasant symptoms. These 
mothers are shown to consume less alcohol. Investigators 
demonstrate that the instrumental variable, unlike alcohol 
consumption, is unrelated to potential confounders of the 
association between prenatal alcohol exposure and academic 
achievement such as socioeconomic status. While traditional 
regression analyses based on the alcohol consumption expo-
sure variable have returned ambiguous results, presumably 
due to residual confounding (eg, maternal wine consump-
tion being protective for child  educational attainment), the 
instrumental variable analyses demonstrate robust positive 
effects on child educational achievement in children whose 
mothers were induced by their genotype to abstinence or 
lower alcohol consumption in pregnancy.
Twin or sibling studies attempt to eliminate confounding 
by genetic and environmental factors, eg, uterine environ-
ment, parental education, parenting style, home/family envi-
ronment, neighborhood, educational, and socioeconomic 
factors.28,33,40,75 In a monozygotic concordant-discordant 
design, participants in each group share the same genetics 
and family-level environmental factors.75 Differences in neu-
rodevelopmental outcome across groups would then reflect 
the toxic effect of general anesthesia/surgery.
Longitudinal study designs, where neurodevelopment 
is repeatedly assessed over time, allow children to serve as 
their own controls.66,68,71 This approach mitigates confound-
ing by static confounders, eg, genetics and socioeconomic 
status.
Finally, other approaches may dispense with control 
groups altogether. One could focus on the interaction 
between general anesthesia and age at exposure, ie, compare 
children who undergo early versus late surgery.9,29,39,46,81,94 
Associations would not be confounded by diagnosis and 
surgery/anesthetic factors since all subjects could be simi-
larly exposed. However, this approach mandates that sur-
gery can be postponed, which is not always feasible.
DETECTING MODEST NEUROTOXIC EFFECTS
In utero or early childhood exposure to a range of neu-
rotoxicants (eg, metals, organic solvents, pesticides) 
Figure 3.  Contrasting the conduct of (A) randomized controlled trials and (B) Mendelian randomization studies. See text for full explanation.
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can adversely affect neurobehavioral development.110,111 
Ethanol, like anesthetic agents, acts at γ-aminobutyric 
acid and N-methyl-d-aspartic acid receptors and causes 
neuronal apoptosis in the developing brain.92 Robust det-
rimental associations between heavy and binge prenatal 
alcohol exposure and adverse child neurodevelopment 
are established.112,113 However, studies of light-to-moderate 
prenatal alcohol exposure have suffered from residual con-
founding and have reported inconsistent conclusions even 
with sample sizes in the order of 10,000 children. We can 
presume that large samples will similarly be required to 
reliably detect any long-term neurotoxic effects following 
childhood general anesthesia—an effect that may also be 
comparable or small relative to the effects of confounding 
factors.9,25,39,47,73,82 Large samples are also required to per-
mit adjustment or matching techniques to account for con-
founding. Existing anesthetic-induced neurotoxicity studies 
vary in size between 15 and 125,000 subjects with a median 
131 children (interquartile range, 50–372), so are often likely 
to be underpowered and potentially falsely reassuring.
Besides pursuing larger sample sizes, comparing 
exposed children with unexposed children in 1:4 ratio to 
maximize statistical power,38,47,48 avoiding short-duration 
interventions (eg, maternal general anesthesia for cesarean 
delivery or myringotomy and grommet insertion), study-
ing exposure during the “vulnerable time window” of brain 
development, and using sensitive outcome measures are 
strategies that may increase the likelihood of detecting the 
neurotoxic effects of general anesthesia.
NEURODEVELOPMENTAL OUTCOME
The neurodevelopmental outcome measures reported in the 
literature vary and encompass (a) intelligence/cognition, 
(b) academic achievement, (c) development/behavior, and 
(d) neuropsychiatric diagnoses, ie, attention-deficit/hyper-
activity disorder, autism spectrum disorder, and learning 
disability.49 Prospective evaluation in multiple domains 
of development using a battery of sensitive, validated 
outcomes and trained, blinded assessors is the gold stan-
dard. However, the risk of detecting spurious associations 
increases with multiple outcomes. Therefore, it is wise to 
caution against the overinterpretation of solitary detrimen-
tal associations in the context of a panel of otherwise reas-
suring results.
Measures of intelligence/cognition are thought to remain 
stable throughout the life course unless disrupted by severe 
disease.49,114 However, assessment is not feasible until basic 
cognitive skills are achieved by 4–6 years of age.49,50 Age-
normalized intelligence scores permit comparisons of out-
come at different ages and enable referencing to population 
scores.104
Academic achievement in standardized national tests 
reflects intelligence/cognition,115 but is muddied by mul-
tiple external factors, eg, self-esteem and lifestyle factors.49 
School grade performance in children with dyslexia or dys-
praxia may be boosted by extra help in school, mitigating 
any negative effect on academic achievement.26 Although 
standardized national tests are administered at popula-
tion level, which makes them a feasible outcome for large 
population studies, not all children participate, eg, private 
schools or nonentry due to learning difficulty.8 However, 
investigating academic achievement does confer the prag-
matic advantage that parents/guardians are likely to be 
highly invested in their child’s school performance.27
Child development evolves in surges and plateaus, ref-
erenced to well-defined developmental milestones expected 
at certain ages, which permits outcome assessment even at 
the youngest ages.49 The reliability of subjective develop-
mental/behavioral data collected through parental survey 
is questionable: developmental delay in language/speech, 
mathematics, and reading domains may not be noticed 
until challenged in school; behavioral problems may not 
manifest until children communicate and interact with their 
peers in school.34,38,48,89 An ideal anesthetic-induced neuro-
toxicity study should use trained, blinded assessors (eg, 
pediatric neuropsychologists) to measure outcome using 
a comprehensive battery of developmental assessments. 
Scores generated by this method of outcome assessment are 
objective and highly sensitive to subtle neurotoxic effects 
that may be difficult to detect clinically.34 The use of such 
comprehensive neurodevelopmental assessments is most 
feasible in smaller studies, which prospectively assess out-
come,27 but it is also available in some retrospective data 
sets.73 The Bayley Scales of Infant Development28,34 is the 
most extensively used example,116 but the latest third ver-
sion may overestimate development in certain groups,117,118 
and caution is required if comparisons are made with scores 
from previous iterations.119
Neuropsychiatric diagnoses for developmental/behav-
ioral disorders are multifactorial in origin (including 
genetic predisposition), with a heterogeneous and changing 
clinical presentation over time.49 Children may spontane-
ously “catch-up”40 or benefit from supportive interventions 
in childhood.49,81 Neuropsychiatric diagnoses are almost 
exclusively parameterized as binary outcomes (eg, from 
International Classification of Diseases, Ninth Revision diagno-
sis codes, school or health care records) as opposed to “risk 
scores.” These binary outcomes are likely to be too crude/
insensitive to detect any subtle effects of anesthetic expo-
sure.21 Nondiagnosis (especially before the group communi-
cation/interaction and higher cognitive demands placed on 
schoolchildren34,48), underreporting, and incorrect diagnosis 
coding in databases is likely to introduce misclassification 
bias. Studying learning disability confers particular advan-
tages though: a high incidence (5%–10%) and recording in 
large educational databases.49
POSTOPERATIVE FOLLOW-UP AND SAMPLE 
ATTRITION
The time interval between anesthesia and first neurodevel-
opmental assessment must be sufficiently long to distinguish 
long-term neurotoxic effects from short-term postoperative 
cognitive-behavioral changes (ie, ≥6 months46). It must also 
allow sufficient latency for marginal neurodevelopmen-
tal deficits to manifest in domains of development, which 
emerge, differentiate, and are amenable to thorough neuro-
psychological testing at older ages, eg, cognitive skills such as 
language/speech/reading, mathematics, memory, and exec-
utive functioning from late childhood.14,24,33 Furthermore, 
neurodevelopmental evaluation in school children is known 
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to be more robust and predictive for adulthood than when 
measured in preschool children because of the variability in 
young children’s developmental trajectories.14,22,24,52,60 There 
has been concern that multiple life course factors may dilute 
any differences in outcome between exposed and unexposed 
children after such long follow-up. However, subtle associa-
tions between starting school in January versus December 
and educational achievement and intelligence quotient 
scores have been detected in large cohorts as late as 18 years 
old.47 Existing studies of anesthetic-induced neurotoxicity 
follow up children until a median age of 6 years (interquar-
tile range, 2–12 years).
Prolonged follow-up makes retrospective or ambidirec-
tional (meaning retrospective ascertainment of exposure 
but prospective measurement of outcome) studies28,33,93,96 
efficient compared to prospective randomized and non-
randomized designs. But it also makes sample attrition 
(eg, due to withdrawal, death, migration, moving schools, 
or health care provider) a significant problem, eg, 50% of 
initially enrolled children completing assessment at 2 years 
in 1 study.66 Most observational studies report a “complete 
case analysis,” in which any children with missing data are 
disregarded.8,24,27,30,52,89,93 The amount of missing data and 
reasons for this are frequently omitted. As well as suffering 
a reduction in precision, their results may be biased when 
neurodevelopmental outcome data are missing nonran-
domly.51,73 For example, if general anesthesia slowed child 
neurodevelopment, then exposed children may be lost to 
follow-up if they were unable or reluctant to engage in intel-
ligence testing. Effect estimates would then underestimate 
the true effect of general anesthesia in the complete case 
analysis.
Even research funded to intensively follow up children 
in prospective randomized or nonrandomized studies will 
have missing data. Statistical methods can be used to per-
mit unbiased analyses without excluding affected cases.51 
Choice of method depends on the probable mechanism of 
data loss. Multiple imputation is a popular technique used 
when data are believed to be missing at random. Missing 
data are inferred from a rich observed data set to construct 
multiple plausible data sets, which are pooled to produce 
a result that reflects the uncertainty in the imputed data. 
Data that are missing not at random can only be addressed 
through experiments that test the sensitivity of results to 
different mechanisms of data loss.
INTERPRETING RESULTS IN CLINICAL PRACTICE
Despite considerable interest and anxiety, there is at present 
no conclusive evidence or consensus that general anesthe-
sia harms the developing brain. Childhood general anesthe-
sia typically comprises single short exposures and is likely 
to carry low risk.14,33,120 However, if general anesthesia is 
thought to pose long-term neurodevelopmental risks, then 
the impacts on clinical practice could be far reaching.
In considering the current clinical implications, it should 
be noted that the evidence base is comprised mainly of 
retrospective observational studies, whose subjects were 
anesthetized in the 1970s–1990s, since when there have 
been widespread changes in practice. Pediatric anesthesia 
may have become safer32 as isoflurane/sevoflurane and IV 
anesthesia have replaced the “Liverpool technique” (muscle 
relaxation and nitrous oxide for neonatal procedures), halo-
thane, enflurane, and methoxyflurane53; and our profes-
sion became more conscious of optimal fluid management, 
adopted obligatory multiparameter monitoring incorporat-
ing pulse oximetry and capnography; and there have been 
changes in who is delivering anesthetic care to children.74
Nonetheless, if the evidence base becomes stronger, then 
surgeons, physicians, and general practitioners will require 
a new appreciation of the neurotoxic risks of anesthesia to 
inform clinical decision making and the consent process. 
Important topics for discussion with children, parents, or 
guardians would include which elective procedures could 
be deferred, the associated risks of delay, alternative anes-
thetic management (eg, alternative anesthetic agents or 
regional techniques), and possible mitigating or protective 
strategies.28
Withholding general anesthetic drugs during neona-
tal surgery (eg, the “Liverpool technique”) may not be 
an option today and is certainly unethical in later child-
hood. Painful stimulation and the associated strong stress 
response are also thought to impair neurodevelopment.27,121
Modifiable factors certainly include optimizing periop-
erative physiology, good perioperative analgesia, psycho-
social support, and avoidance of unpleasant experiences 
or prolonged hospitalization. Determining which general 
anesthetic drugs and techniques might carry the lowest risk 
will require researchers to accurately quantify the dura-
tion, cumulative dose, and interactions of specific agents.33 
Whether time to allow remodeling/repair between sequen-
tial general anesthesia can mitigate neurotoxic damage 
could be investigated.9 Neuroprotection afforded by strict 
maintenance of physiological parameters, pharmacothera-
pies, preconditioning, and novel neurogenesis techniques 
are being researched.63,88 Maintaining cerebral glucose and 
oxygen delivery by minimizing cardiopulmonary bypass 
and deep hypothermic circulatory arrest times may play a 
role in pediatric cardiac surgery.63,68
Most general anesthesia is provided for healthy elec-
tive cases. Here, the physical or psychosocial harms of 
deferring or cancelling surgery or procedures would need 
careful weighing against the risk and impact of potential 
neurodevelopmental impairment on the individual, espe-
cially for repeated or prolonged anesthesia. For example, 
impaired wound healing and cosmesis, concerns about 
impaired speech/language development, and social stigma 
may preclude deferral of surgery in cleft lip and palate.94 
The current level of concern about neurotoxicity would not 
preclude the provision of general anesthesia for emergency 
surgery or cesarean delivery.
High-risk groups for poor developmental outcome (eg, 
multiple prolonged general anesthesia) may require follow-
up neurodevelopmental screening with the option of refer-
ral for early school intervention programs to attempt to 
mitigate any harms and improve developmental acquisition 
and school performance.122
CONCLUSIONS
Despite growing international concern that general anes-
thesia in childhood leads to long-term neurodevelopmental 
impairment, delineating general anesthesia–induced effects 
from those of surgery remains a significant challenge in the 
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study of anesthetic-induced neurotoxicity. Deficiencies of 
existing research also include inconsistent exposure defini-
tions, selection of cohorts with independent risk factors for 
impaired neurodevelopment, extensive confounding, the 
need to detect subtle neurotoxic effects, blunt neurodevel-
opmental assessment tools, and sample attrition over the 
long-term follow-up required.
Randomized controlled trials represent the gold standard 
tool in the present climate of clinical equipoise.14 However, 
randomly assigning children to general anesthesia-surgery 
versus regional anesthesia-surgery versus no anesthesia-no 
surgery poses significant ethical and logistical challenges, 
particularly if prolonged or repeated general anesthesia is 
to be studied. This coupled with the large sample sizes and 
prolonged follow-up required to detect neurotoxic effects 
necessitates the design of more efficient, sophisticated obser-
vational studies1,33,123 and has driven calls for the adoption of 
surrogate indices such as neuroimaging and biomarker tech-
niques to evaluate neuronal inflammation and apoptosis.124
Large observational studies can produce more precise, 
more timely results that are not constrained to studying single 
short general anesthesia exposures. We advocate prospective 
or ambidirectional cohort studies that accurately ascertain 
general anesthesia exposure, rigorously control for confound-
ers, and prospectively follow up neurodevelopment into ado-
lescence. They will also permit researchers to elucidate the 
role of potential mediators and effect modifiers of any neuro-
toxic effect to inform strategies to mitigate the potential neu-
rotoxic risks of general anesthesia in early childhood.
In parallel, there is a need for ongoing animal work to 
characterize the mechanisms of anesthetic-induced neu-
rotoxicity, the relative neurotoxic potentials of different 
anesthetic agents at different stages of development, and 
modifiable factors to reduce anesthetic-induced neurotoxic-
ity. These animal studies will need to more carefully control 
physiological parameters and anesthetic dosing and more 
closely mimic the surgical insult if their findings are to be 
generalizable to human pediatric anesthesia.
Given the inherent challenges of studying anesthetic-
induced neurotoxicity, we must acknowledge that it may 
never be possible to demonstrate anesthetic-induced neuro-
toxicity in conventional clinical trials. Ultimately, multiple 
complementary approaches are required to accumulate suf-
ficient evidence to inform a consensus opinion on the neu-
rotoxic potential of general anesthesia—currently, the single 
greatest issue in modern pediatric anesthetic practice. E
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